Found 70 clinical trials
AdaptResponse Clinical Trial
AdaptResponse Clinical Trial
- 60 views
- 08 Nov, 2020
- 1 location
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
Resynchronisation Therapy, the implantation of a pacemaker (index group) is not inferior to defibrillator (control group) with respect to all-cause mortality.
- 2 views
- 24 Jul, 2021
- 353 locations
Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing in CRT canDidates
Cardiac resynchronization therapy (CRT) is a recommended treatment for selected patients with symptomatic heart failure (HF). Although most treated patients show a benefit from CRT, a lack of
- 0 views
- 22 Jan, 2021
Acute Changes in Bioimpedance During Cardiac Resynchronization Therapy
This study aims at Optimizing measured parameters to reflect underlying pathology in dyssynchronous hearts. This is an experimental study in patients were bioimpedance measurements are performed during implantation.
- 3 views
- 22 Jan, 2021
- 1 location
Stem Cells and Resynchronization Cardiac
Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class
- 18 views
- 07 Nov, 2020
- 1 location
The Effects of Anodal Stimulation on Echocardiographic Outcome in Patients With Cardiac Resynchronization Therapy
To investigate the hemodynamic, inter and intraventricular desynchrony effects of anodal stimulation and triple site pacing compared with the usual dual site pacing by echocardiography and Tissue Doppler Imaging.
- 1 views
- 07 Nov, 2020
- 1 location
ECG Belt vs. Echocardiographic Optimization of CRT
Cardiac resynchronization therapy (CRT) has been a valuable intervention for patients with systolic heart failure for over 15 years. Despite years of research, there is a still a 25-40% non
- 0 views
- 26 May, 2021
- 1 location
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
Cardiac resynchronization therapy (CRT), or atrial-synchronized biventricular (BiV) pacing, is an FDA-approved device therapy option for heart failure (HF) patients with reduced left ventricular
- 0 views
- 27 May, 2021
- 2 locations
Tailoring Pacemaker Output to Physiology in Chronic Heart Failure
resynchronization therapy (CRT) can improve symptoms and prognosis by retuning the timing of the contraction of the heart. However, the effect of CRT is variable and unpredictable, with around 1 in 3 of people
- 0 views
- 07 May, 2021
- 1 location
Efficacy Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy
The primary objective is to determine whether comprehensive remote follow-up in HF patients with CRT will reduce the combined endpoint of all-cause mortality or worsening heart failure hospitalizations, whichever comes first, when compared to basic remote monitoring, over a 27-month follow-up.
- 22 views
- 25 Jan, 2021
- 1 location